St. Louis, MO, United States of America

Robert W Karr

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Milpitas, CA (US) (1992)
  • St. Louis, MO (US) (2019 - 2020)
  • Frontenac, MO (US) (2022 - 2023)

Company Filing History:


Years Active: 1992-2023

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert W Karr

Introduction

Robert W Karr is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of therapeutic antibodies, particularly in the development of anti-CD47 monoclonal antibodies. With a total of 5 patents to his name, Karr's work has the potential to impact various medical conditions, including cancers and autoimmune diseases.

Latest Patents

Karr's latest patents focus on therapeutic CD47 antibodies. These patents provide anti-CD47 monoclonal antibodies (anti-CD47 mAbs) with distinct functional profiles. The methods described include generating these antibodies and utilizing them as therapeutics for the prevention and treatment of solid and hematological cancers, ischemia-reperfusion injury, cardiovascular diseases, autoimmune diseases, and inflammatory diseases. Additionally, these antibodies can serve as diagnostics for determining the level of CD47 in tissue samples. Another aspect of his patents includes monoclonal antibodies and antigen-binding fragments that bind to and inhibit the activity of CD47. These compounds are effective in treating tissue ischemia, autoimmune and inflammatory diseases, and as anti-cancer agents.

Career Highlights

Throughout his career, Robert W Karr has worked with various companies, including Arch Oncology, Inc. His innovative work in the field of therapeutic antibodies has positioned him as a key figure in medical research and development.

Collaborations

Karr has collaborated with notable individuals in his field, including Pamela T Manning and Robyn Puro. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Robert W Karr's contributions to the field of therapeutic antibodies demonstrate his commitment to innovation and improving medical treatments. His work continues to pave the way for advancements in the prevention and treatment of serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…